Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 125

1.

HIV laboratory monitoring reliably identifies persons engaged in care.

Dean BB, Hart RL, Buchacz K, Bozzette SA, Wood K, Brooks JT; HOPS Investigators.

J Acquir Immune Defic Syndr. 2015 Feb 1;68(2):133-9. doi: 10.1097/QAI.0000000000000406.

PMID:
25383710
2.

Outcomes associated with conventional versus lipid-based formulations of amphotericin B in propensity-matched groups.

Campbell RS, Chaudhari P, Hays HD, Taylor RJ, Nathanson BH, Bozzette SA, Horn DL.

Clinicoecon Outcomes Res. 2013 Oct 24;5:507-17. doi: 10.2147/CEOR.S46834. eCollection 2013.

3.

A probability sample for monitoring the HIV-infected population in care in the U.S. and in selected states.

Frankel MR, McNaghten A, Shapiro MF, Sullivan PS, Berry SH, Johnson CH, Flagg EW, Morton S, Bozzette SA.

Open AIDS J. 2012;6:67-76. doi: 10.2174/1874613601206010067. Epub 2012 Sep 7.

4.

HIV and Cardiovascular Disease.

Bozzette SA.

Clin Infect Dis. 2011 Jul 1;53(1):92-3. doi: 10.1093/cid/cir275. No abstract available.

5.

Quality of care for patients infected with HIV.

Bozzette SA.

Clin Infect Dis. 2010 Sep 15;51(6):739-40. doi: 10.1086/655894. No abstract available.

6.

Fluconazole alone or combined with flucytosine for the treatment of AIDS-associated cryptococcal meningitis.

Milefchik E, Leal MA, Haubrich R, Bozzette SA, Tilles JG, Leedom JM, McCutchan JA, Larsen RA.

Med Mycol. 2008 Jun;46(4):393-5. doi: 10.1080/13693780701851695.

PMID:
18415850
7.

Long-term survival and serious cardiovascular events in HIV-infected patients treated with highly active antiretroviral therapy.

Bozzette SA, Ake CF, Tam HK, Phippard A, Cohen D, Scharfstein DO, Louis TA.

J Acquir Immune Defic Syndr. 2008 Mar 1;47(3):338-41. doi: 10.1097/QAI.0b013e31815e7251.

PMID:
18176330
8.

Prevalence of HIV infection among inpatients and outpatients in Department of Veterans Affairs health care systems: implications for screening programs for HIV.

Owens DK, Sundaram V, Lazzeroni LC, Douglass LR, Sanders GD, Taylor K, VanGroningen R, Shadle VM, McWhorter VC, Agoncillo T, Haren N, Nyland J, Tempio P, Khayr W, Dietzen DJ, Jensen P, Simberkoff MS, Bozzette SA, Holodniy M.

Am J Public Health. 2007 Dec;97(12):2173-8. Epub 2007 Oct 30.

9.

Non-pharmaceutical public health interventions for pandemic influenza: an evaluation of the evidence base.

Aledort JE, Lurie N, Wasserman J, Bozzette SA.

BMC Public Health. 2007 Aug 15;7:208. Review.

10.

HIV testing of at risk patients in a large integrated health care system.

Owens DK, Sundaram V, Lazzeroni LC, Douglass LR, Tempio P, Holodniy M, Sanders GD, Shadle VM, McWhorter VC, Agoncillo T, Haren N, Chavis D, Borowsky LH, Yano EM, Jensen P, Simberkoff MS, Bozzette SA.

J Gen Intern Med. 2007 Mar;22(3):315-20.

11.

Survival curve estimation for informatively coarsened discrete event-time data.

Shardell M, Scharfstein DO, Bozzette SA.

Stat Med. 2007 May 10;26(10):2184-202.

PMID:
16998829
12.

An HIV collaborative in the VHA: do advanced HIT and one-day sessions change the collaborative experience?

Fremont AM, Joyce G, Anaya HD, Bowman CC, Halloran JP, Chang SW, Bozzette SA, Asch SM.

Jt Comm J Qual Patient Saf. 2006 Jun;32(6):324-36.

PMID:
16776387
13.

Transmission patterns of smallpox: systematic review of natural outbreaks in Europe and North America since World War II.

Bhatnagar V, Stoto MA, Morton SC, Boer R, Bozzette SA.

BMC Public Health. 2006 May 5;6:126. Review.

14.

The effect of socioeconomic status on the survival of people receiving care for HIV infection in the United States.

Cunningham WE, Hays RD, Duan N, Andersen R, Nakazono TT, Bozzette SA, Shapiro MF.

J Health Care Poor Underserved. 2005 Nov;16(4):655-76.

PMID:
16311491
15.
16.

Fluconazole prophylaxis in HIV disease, revisited.

Bozzette SA.

Clin Infect Dis. 2005 Nov 15;41(10):1481-2. Epub 2005 Oct 12. No abstract available.

17.

Routine screening for HIV infection--timely and cost-effective.

Bozzette SA.

N Engl J Med. 2005 Feb 10;352(6):620-1. No abstract available.

PMID:
15703428
18.

A national study of the relationship of care site HIV specialization to early adoption of highly active antiretroviral therapy.

Wilson IB, Landon BE, Ding L, Zaslavsky AM, Shapiro MF, Bozzette SA, Cleary PD.

Med Care. 2005 Jan;43(1):12-20.

PMID:
15626929
19.

The prevalence of antiretroviral drug resistance in the United States.

Richman DD, Morton SC, Wrin T, Hellmann N, Berry S, Shapiro MF, Bozzette SA.

AIDS. 2004 Jul 2;18(10):1393-401.

PMID:
15199315
20.

Lipid screening in HIV-infected veterans.

Korthuis PT, Asch SM, Anaya HD, Morgenstern H, Goetz MB, Yano EM, Rubenstein LV, Lee ML, Bozzette SA.

J Acquir Immune Defic Syndr. 2004 Mar 1;35(3):253-60.

PMID:
15076239
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk